Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-45774

Single-particle
3.44 Å
EMD-45774
3D View Gallery
Deposition: 16/07/2024
Map released: 20/11/2024
Last modified: 11/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-45774
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9co9 summary report (pdf.gz) Map and 9co9 FULL report (pdf.gz)
EMICSS annotations (xml)

Local refinement of JN.1 spike/Nanosota-9 complex

EMD-45774

Single-particle
3.44 Å
EMD-45774
3D View Gallery
Deposition: 16/07/2024
Map released: 20/11/2024
Last modified: 11/12/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Vicugna pacos
Sample: JN.1 spike/Nanosota-9 complex
Fitted models: 9co9

Deposition Authors: Ye G, Bu F, Liu B , Li F
Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate.
Ye G, Bu F, Saxena D, Turner-Hubbard H, Herbst M, Spiller B, Wadzinski BE, Du L, Liu B , Zheng J, Li F
(2024) PLoS Pathog , 20 , e1012726 - e1012726
PUBMED: 39591462
DOI: doi:10.1371/journal.ppat.1012726
ISSN: 1553-7374